Notice2022-07368
Bulk Manufacturer of Controlled Substances Application: Purisys, LLC
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 7, 2022
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
Purisys, LLC. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTAL INFORMATION listed below for further drug information.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 67 (Thursday, April 7, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 67 (Thursday, April 7, 2022)]
[Notices]
[Page 20464]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-07368]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-988]
Bulk Manufacturer of Controlled Substances Application: Purisys,
LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Purisys, LLC. has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTAL INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before June 6, 2022.
Such persons may also file a written request for a hearing on the
application on or before June 6, 2022.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on January 21, 2022, 1550 Olympic Drive, Athens, Georgia
30601-1602, applied to be registered as a bulk manufacturer of the
following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Cathinone............................... 1235 I
Gamma Hydroxybutyric Acid............... 2010 I
Lysergic acid diethylamide.............. 7315 I
Marihuana Extract....................... 7350 I
Marihuana............................... 7360 I
Tetrahydrocannabinols................... 7370 I
2,5-Dimethoxyamphetamine................ 7396 I
3,4-Methylenedioxy 7400 I
amphetamine............................
5-Methoxy-3,4-methylenedioxy amphetamine 7401 I
3,4-Methylenedioxy 7405 I
methamphetamine........................
5-Methoxy-N-N-dimethyl 7431 I
tryptamine.............................
Diethyltryptamine....................... 7434 I
Dimethyltryptamine...................... 7435 I
Psilocybin.............................. 7437 I
Psilocyn................................ 7438 I
Codeine-N-oxide......................... 9053 I
Dihydromorphine......................... 9145 I
Hydromorphinol.......................... 9301 I
Morphine-N-oxide........................ 9307 I
Normorphine............................. 9313 I
Norlevorphanol.......................... 9634 I
Codeine................................. 9050 II
Dihydrocodeine.......................... 9120 II
Oxycodone............................... 9143 II
Hydromorphone........................... 9150 II
Hydrocodone............................. 9193 II
Levorphanol............................. 9220 II
Morphine................................ 9300 II
Oripavine............................... 9330 II
Thebaine................................ 9333 II
Opium tincture.......................... 9630 II
Opium, powdered......................... 9639 II
Opium, granulated....................... 9640 II
Oxymorphone............................. 9652 II
Noroxymorphone.......................... 9668 II
Alfentanil.............................. 9737 II
Sufentanil.............................. 9740 II
Carfentanil............................. 9743 II
Tapentadol.............................. 9780 II
Fentanyl................................ 9801 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for internal use intermediates or for sale to its customers.
The company plans to manufacture the above-listed controlled substances
as clinical trial and starting materials to make compounds for
distribution to its customers. No other activities for these drug codes
are authorized for this registration.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-07368 Filed 4-6-22; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on April 7, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.